Nuplazid – Pimavanserin 17 mg is supplied for Tenders, Emergency imports, Orphan drug, Reference listed drugs, Comparator Drug, Name patient medicine and Innovator samples etc.

Uses of medication: Pimavanserin (Nuplazid) specifically is an atypical antipsychotic used in order to treat hallucinations and delusions associated with Parkinson’s disease psychosis.

Dosage: The recommended dose of Nuplazid is 34mg, which should be taken orally once a day either with or without food. Nuplazid capsules should not be chewed or crushed. It should be swallowed whole.

Treatment Reactions: The most commonly reported pimavanserin side effects include:

  • Peripheral Edema
  • Nausea
  • Confusional State
  • Hallucination
  • Constipation
  • Gait Disturbance

Warnings and Precautions:

  • The nuplazid uses should be avoided in patients with severe renal impairment.
  • Nuplazid uses are contraindicated in patients with the history of hypersensitivity reactions to pimavanserin or any of its existing components.
  • Use of nuplazid 34 mg is not recommended in patients with hepatic impairment.
  • Concomitant use of strong/moderate CYP3A4 inducers with pimavanserin should be avoided
  • The nuplazid dosing should be avoided in patients with known QT prolongation or along with other drugs known to prolong the QT interval.
  • Women with childbearing potential should discuss with their healthcare practitioner before starting pimavanserin dosage.
  • Patients taking this medication are advised that inform their doctor prior to breastfeeding.